Dr Mark Owens Thornton, MD | |
26120 Kings Valley Rd, Damascus, MD 20872-1633 | |
(301) 253-0854 | |
Not Available |
Full Name | Dr Mark Owens Thornton |
---|---|
Gender | Male |
Speciality | General Practice |
Location | 26120 Kings Valley Rd, Damascus, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1972873461 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | D0050387 (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Mark Owens Thornton, MD 26120 Kings Valley Rd, Damascus, MD 20872-1633 Ph: () - | Dr Mark Owens Thornton, MD 26120 Kings Valley Rd, Damascus, MD 20872-1633 Ph: (301) 253-0854 |
News Archive
A 64-year-old female patient with mediastinal metastasis recently became the first in Latin America to receive Elekta VMAT radiotherapy treatment enhanced with Monaco® planning software. Using the arc-based Elekta VMAT delivery method, Monaco displays how the radiation dose should be applied — its distribution and strength on the target. The result is a therapy that not only is rapid, but also fine-tuned to treat cancer and avoid healthy tissues.
Cognitive behavioral therapy is a widely used nonpharmacologic treatment for insomnia disorders and an analysis of the medical literature by sleep researchers at Rush University Medical Center suggests it also can work for patients whose insomnia is coupled with psychiatric and medical conditions, according to an article published online by JAMA Internal Medicine.
The Harvard Clinical Research Institute announced today that the DAPT Study has expanded into seven countries in the European Union. John Irving, MBChB, MRCP, M.D., consultant cardiologist at Ninewells Hospital in Dundee, United Kingdom, was the first European investigator to enroll patients into the study.
Syneron Medical Ltd., the global leader in the medical aesthetic device marketplace, announced today the US Food and Drug Administration (FDA) and Health Canada clearance and commercial launch of its highly flexible CO2RE CO2 resurfacing system. CO2RE is a versatile fractional CO2 system that offers the unique ability to treat both superficial and deep skin layers simultaneously with precision-control over the intensity, pattern and depth of ablation.
› Verified 8 days ago
Kenneth Joel Weiss, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 9890 Main Street Rear, Damascus, MD 20872 Phone: 301-253-6977 Fax: 301-253-9091 |